You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage II

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Kidney Failure, End Stage Renal Disease, Hypotension Trial in Ann Arbor (Patient Activation, Provider Education)

Suspended
  • Kidney Failure
  • +4 more
  • Patient Activation
  • Provider Education
  • Ann Arbor, Michigan
    Fresenius Kidney Care University Of Michigan - Ann Arbor
Nov 22, 2021

High Grade Glioma, Meningioma, Embryonal Tumor Trial in United States (LUTATHERA® (Lutetium Lu 177 dotatate))

Recruiting
  • High Grade Glioma
  • +12 more
  • LUTATHERA® (Lutetium Lu 177 dotatate)
  • Aurora, Colorado
  • +8 more
Jan 16, 2023

Parkinson Disease Trial in Lille (A-dopamine, optimized oral treatment)

Recruiting
  • Parkinson Disease
  • Lille, France
    Hopital Roger Salengro, CHU Lille
Oct 11, 2022

Breast Cancer Trial in Baltimore (FBnTP)

Terminated
  • Breast Cancer
  • Baltimore, Maryland
    Johns Hopkins Hospital
Dec 14, 2021

NSCLC, Stage IIIA, EGF-R Negative NSCLC, ALK Negative NSCLC Trial in Shanghai (PD-1 and chemo)

Recruiting
  • NSCLC, Stage IIIA
  • +2 more
  • PD-1 and chemotherapy
  • Shanghai, Shanghai, China
    Shanghai General Hospital
Dec 14, 2021

HFI Trial in Maastricht (PF-06801591)

Recruiting
  • HFI
  • Maastricht, Limburg, Netherlands
    Maastricht University Medical centre
Oct 16, 2023

Patients With NSCLC Trial in Xi'an (Simultaneous chemoradiotherapy for An Luo)

Unknown status
  • Patients With Non-small Cell Lung Cancer
  • Simultaneous chemoradiotherapy for An Luo
  • Xi'an, Shaanxi, China
    The second affiliated Hospital of Xi'an Jiaotong University
Nov 27, 2019

Postoperative Nausea, Vomiting Trial in Ankara (Aprepitant, Granisetron)

Not yet recruiting
  • Postoperative Nausea
  • Vomiting
  • Ankara, Turkey
    Baskent University Ankara Hospital
Nov 18, 2022

Low Back Pain, Sciatica, Back Related Leg Pain Trial in Minneapolis, Pittsburgh (Supported Biopsychosocial Self-Management

Active, not recruiting
  • Low Back Pain
  • +4 more
  • Supported Biopsychosocial Self-Management (SBSM)
  • Medical Care
  • Minneapolis, Minnesota
  • +1 more
Nov 3, 2022

Marginal Zone Lymphoma, Nodal Marginal Zone Lymphoma, Splenic Marginal Zone Lymphoma Trial in Worldwide (Ibrutinib, Rituximab)

Recruiting
  • Marginal Zone Lymphoma
  • +2 more
  • Yvoir, Belgium
  • +36 more
Nov 4, 2022

Pregnancy Preterm, Pregnancy Prom, PROM, Preterm (Pregnancy) Trial (Azithromycin Pill, Amoxicillin Pill)

Not yet recruiting
  • Pregnancy Preterm
  • +5 more
  • Azithromycin Pill
  • Amoxicillin Pill
  • (no location specified)
Jun 3, 2022

Treating Patients With Stage IV Breast Cancer

Active, not recruiting
  • Central Nervous System Metastases
  • +15 more
  • hyperfractionated radiation therapy
  • +2 more
  • North Chicago, Illinois
    University of Chicago
Dec 6, 2021

Acute Lymphoblastic Leukemia, Relapsed Pediatric ALL, Refractory Acute Lymphoblastic Leukemia Trial in Wuhan (pCAR-19B cells)

Completed
  • Acute Lymphoblastic Leukemia
  • +2 more
  • pCAR-19B cells
  • Wuhan, Hubei, China
    Tongji Hospital affiliated to Tongji Medical College of Huazhong
Mar 16, 2022

Omitting Clinical Target Volume of Unresectable Stage III

Completed
  • Stage III Non-small-cell Lung Cancer
  • The enrollment was randomly (1:1) assigned into the study group with CTV-omitted IMRT under PET-CT guidance and the control group with CTV-delineated IMRT using a random number table.
  • (no location specified)
Aug 29, 2022

Chronic Lymphocytic Leucemia Trial in Cologne (Bendamustine, GA101, CAL-101)

Active, not recruiting
  • Chronic Lymphocytic Leucemia
  • Cologne, Germany
    German CLL Study Group
Apr 29, 2022

Sarcoma Trial in Turin (Autologous CIK)

Recruiting
  • Sarcoma
  • Autologous CIK
  • Turin, Italy
    AOU Città della Salute e della Scienza di Torino - Presidio Infa
Aug 11, 2022

Cataract, Corneal Astigmatism Trial in United States (TECNIS® Toric II)

Completed
Has Results
  • Cataract
  • Corneal Astigmatism
  • TECNIS® Toric II
  • Bakersfield, California
  • +6 more
May 5, 2022

Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Plasma Cell Myeloma Trial in Detroit (The DISCO

Recruiting
  • Chronic Lymphocytic Leukemia
  • +2 more
  • The DISCO App
  • Usual Care
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
May 31, 2022

Metastatic Prostate Cancer, Prostate Cancer Metastatic, Prostate Cancer Trial in United States (Darolutamide, Enzalutamide)

Recruiting
  • Metastatic Prostate Cancer
  • +3 more
  • San Diego, California
  • +11 more
Nov 28, 2022

Axillary Lymph Node Dissection, Pathological Complete Response, Neoadjuvant Systemic Therapy Trial in Nanjing (Stained region

Recruiting
  • Axillary Lymph Node Dissection
  • +4 more
  • Stained region Lymph Node Biopsy (SrLNB)
  • Regional lymph node radiotherapy (RNI) including the axilla
  • Nanjing, China
    The First Affiliated Hospital of Nanjing Medical University
Jul 10, 2023

MDD (MDD) Trial (HS-10353 30mg oral capsules, HS-10353 50mg oral capsules, Placebo for HS-10353 30mg capsules)

Not yet recruiting
  • Major Depressive Disorder (MDD)
  • HS-10353 30mg oral capsules
  • +3 more
  • (no location specified)
Jul 10, 2023

Neurologic Disorder Trial in Vienna (Tele-Reha provided with EvoPads, Paper-based exercises with option to do tele-reha

Not yet recruiting
  • Neurologic Disorder
  • Tele-Reha provided with EvoPads
  • +2 more
  • Vienna, Austria
    Medical University of Vienna
Jul 7, 2023

Depressive Disorder, Major, Borderline Personality Disorder Trial in Stanford (Left Dorsolateral Prefrontal Cortex (L-DLPFC),

Recruiting
  • Depressive Disorder, Major
  • Borderline Personality Disorder
  • Left Dorsolateral Prefrontal Cortex (L-DLPFC)
  • +2 more
  • Stanford, California
    Stanford Hospital
Oct 4, 2021

Hepatocellular Carcinoma Trial in Guangzhou (HAIC, Sorafenib)

Completed
  • Hepatocellular Carcinoma
  • Guangzhou, Guangdong, China
    Cancer Center Sun Yat-sen University
Nov 16, 2021

Diabetes Type 2 Trial in Doha (Metformin, Gliclazide, Sitagliptin)

Active, not recruiting
  • Diabetes Mellitus Type 2
  • Doha, Qatar
    Hamad Medical Corporation
Apr 27, 2022